AAAAAA

   
Results: 1-7 |
Results: 7
Agonists at the alpha 4 beta 2 nicotinic acetylcholine receptors: Structure-activity relationships and molecular modelling
Authors: Tonder, JE Olesen, PH
Citation: Je. Tonder et Ph. Olesen, Agonists at the alpha 4 beta 2 nicotinic acetylcholine receptors: Structure-activity relationships and molecular modelling, CURR MED CH, 8(6), 2001, pp. 651-674
An improved nicotinic pharmacophore and a stereoselective CoMFA-model for nicotinic agonists acting at the central nicotinic acetylcholine receptors labelled by [H-3]-N-methylcarbamylcholine
Authors: Tonder, JE Olesen, PH Hansen, JB Begtrup, M Pettersson, I
Citation: Je. Tonder et al., An improved nicotinic pharmacophore and a stereoselective CoMFA-model for nicotinic agonists acting at the central nicotinic acetylcholine receptors labelled by [H-3]-N-methylcarbamylcholine, J COMPUT A, 15(3), 2001, pp. 247-258
Bioisosteric replacement strategy for the synthesis of 1-azacyclic compounds with high affinity for the central nicotinic cholinergic receptors
Authors: Olesen, PH Tonder, JE Hansen, JB Hansen, HC Rimvall, K
Citation: Ph. Olesen et al., Bioisosteric replacement strategy for the synthesis of 1-azacyclic compounds with high affinity for the central nicotinic cholinergic receptors, BIO MED CH, 8(6), 2000, pp. 1443-1450
Exploring the stereoselectivity in the Peterson reaction of several 2-substituted 1-azabicyclo[2.2.2]octan-3-ones
Authors: Tonder, JE Begtrup, M Hansen, JB Olesen, PH
Citation: Je. Tonder et al., Exploring the stereoselectivity in the Peterson reaction of several 2-substituted 1-azabicyclo[2.2.2]octan-3-ones, TETRAHEDRON, 56(8), 2000, pp. 1139-1146
Potential role of muscarinic receptors in schizophrenia
Authors: Bymaster, FP Shannon, HE Rasmussen, K DeLapp, NW Ward, JS Calligaro, DO Mitch, CH Whitesitt, C Ludvigsen, TS Sheardown, M Swedberg, M Rasmussen, T Olesen, PH Jeppesen, L Sauerberg, P Fink-Jensen, A
Citation: Fp. Bymaster et al., Potential role of muscarinic receptors in schizophrenia, LIFE SCI, 64(6-7), 1999, pp. 527-534
Improving the nicotinic pharmacophore with a series of (isoxazole)methylene-1-azacyclic compounds: Synthesis, structure-activity relationship, and molecular modeling
Authors: Tonder, JE Hansen, JB Begtrup, M Pettersson, I Rimvall, K Christensen, B Ehrbar, U Olesen, PH
Citation: Je. Tonder et al., Improving the nicotinic pharmacophore with a series of (isoxazole)methylene-1-azacyclic compounds: Synthesis, structure-activity relationship, and molecular modeling, J MED CHEM, 42(24), 1999, pp. 4970-4980
1-(1,2,5-thiadiazol-4-yl)-4-azatricyclo[2.2.1.0(2,6)]heptanes as new potent muscarinic M-1 agonists: Structure-activity relationship for 3-aryl-2-propyn-1-yloxy and 3-aryl-2-propyn-1-ylthio derivatives
Authors: Jeppesen, L Olesen, PH Hansen, L Sheardown, MJ Thomsen, C Rasmussen, T Jensen, AF Christensen, MS Rimvall, K Ward, JS Whitesitt, C Calligaro, DO Bymaster, FP Delapp, NW Felder, CC Shannon, HE Sauerberg, P
Citation: L. Jeppesen et al., 1-(1,2,5-thiadiazol-4-yl)-4-azatricyclo[2.2.1.0(2,6)]heptanes as new potent muscarinic M-1 agonists: Structure-activity relationship for 3-aryl-2-propyn-1-yloxy and 3-aryl-2-propyn-1-ylthio derivatives, J MED CHEM, 42(11), 1999, pp. 1999-2006
Risultati: 1-7 |